Kim, Jiho
Li, Chang
Wang, Hongjie
Kaviraj, Swarnendu
Singh, Sanjay
Savergave, Laxman
Raghuwanshi, Arjun
Gil, Sucheol
Germond, Audrey
Baldessari, Audrey
Chen, Bingmae
Roffler, Steve
Fender, Pascal
Drescher, Charles
Carter, Darrick
Lieber, André
Funding for this research was provided by:
DOD Peer Reviewed Cancer Research Program (W81XWH-17-1-0108)
Andy Hill CARE Fund (BRK_201801)
National Institute for Health Care Management Foundation (P51 OD010425)
HDT Bio
Article History
Received: 12 November 2021
Accepted: 21 April 2022
First Online: 11 May 2022
Competing interests
: D.C. is founder of and holds an equity interest in HDT Bio Corp. a company that licensed the JO4 technology and is assisting in its clinical development.